Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
On 21st December, with its shares having previously closed at 1.85p, Yourgene Health* (YGEN) announced a “capital raising” for “not less than £5.0 million” stated to “provide near-term working capital; and facilitate further restructuring of the group's cost base, removing £2.0 million of annual operating expenditure. The company will also utilise any additional net proceeds to fund regulatory approvals and existing product enhancements”. I.e. it was cash crunch ahoy and, having left the fundraise to that point and with stock market conditions dreadful, the raising was at… 0.30p per share! Unsurprisingly, that sunk the shares, but with new capital now raised and sentiment arguably having hit rock bottom, we see some good recovery potential from a current 0.38p offer price. (now 0.41p)
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.